Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics
2010
Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation
2005
CD44: From adhesion molecules to signalling regulators
2003 Standout
Evaluation of the off‐label usage of rituximab in a large teaching hospital in New South Wales
2007
Complement and its role in innate and adaptive immune responses
2009 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Malignancy in organ transplantation:
2002
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells
2005 StandoutNobel
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
Chronic graft-versus-host disease
2003 Standout
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial
2001
Immunotherapy to reconstitute immunity to DNA viruses
2002
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
2008 Standout
Autoimmune diseases and autoimmunity post-bone marrow transplantation
1998
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders
2002
Monoclonal antibodies as therapeutic agents for cancer
2004
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder
2008
Heart and lung transplantation in children
2006
Allogeneic bone marrow transplantation for active Epstein–Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome
2002
Chemical Lectinology: Tools for Probing the Ligands and Dynamics of Mammalian Lectins In Vivo
2015 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies
2005
Changes in the expression of surface receptors on lymphocyte subsets in the elderly: Quantitative flow cytometric analysis
2001
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells
1997
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
1998
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT
2001
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies
1999
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
2001
Aging and Wound Healing
2004 Standout
Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)
2006
Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.
2001
Management of Epstein–Barr Virus-induced Post-transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation
2001
Diffuse large cell lymphoma
2011
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Post-Transplant Lymphoproliferative Disorders
2004
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Diagnosis and Management of Posttransplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients
2001
A Meta-Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web-Based Expression Atlas
2007
Chemical Glycoproteomics
2016 StandoutNobel
Works of Pascal Bourquard being referenced
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
2000
Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
1994
Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
1994
Cell targeting by murine recombinant retroviruses.
1992